News | Radiation Therapy | September 09, 2019

Accuray to Display Motion Synchronization Cancer Treatment Technologies at ASTRO 2019

Synchrony motion tracking for Radixact System, CyberKnife VOLO Optimizer among radiation therapy treatment system highlights

Accuray to Display Motion Synchronization Cancer Treatment Technologies at ASTRO 2019

September 9, 2019 — Accuray announced that it will showcase its motion-synchronization cancer treatment technologies at the upcoming 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 15 - 18 in Chicago. The company will provide multiple opportunities for attendees to explore its new innovations in patient-first cancer treatments, including booth presentations and demonstrations at its Innovation Pavilion and presentations at the Accuray Symposium.

Synchrony Motion Tracking and Correction Technology for the Radixact System to be Unveiled

Accuray has brought its Synchrony motion synchronization technology from the CyberKnife System to the Radixact System. During the meeting, attendees will have the chance to learn how Synchrony for Radixact synchronizes the treatment delivery beam with the movement of the tumor, accurately delivering high doses of radiation directly to the tumor and minimizing dose to healthy tissue, all while the patient breathes naturally. 

Faster Radiation Treatments with the CyberKnife System

Meeting attendees can also hear more about the CyberKnife VOLO Optimizer, a next-generation optimizer that enables physicians to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments. Clinicians now have an option for delivering the same highly precise radiosurgery and stereotactic body radiation therapy (SBRT) treatments of the CyberKnife System, more quickly and for a wider range of patient cases.

Accuray Symposium: Clinicians to Share Treatment Perspectives

At Accuray's Symposium event on, ASTRO meeting attendees will hear how dynamic tracking and motion synchronization has translated into improved patient outcomes. The symposium panelists will discuss their perspectives and share best practices on how they have used Accuray's motion synchronization technologies.

Symposium panelists will include:

  • Symposium Chairman and Introduction: Iris C. Gibbs, M.D., FACR, FASTRO, Stanford University Medical Center, Stanford, Calif.;
  • Clinical Value of Motion Synchronization for Prostate SBRT: Ronald C. Chen, M.D. MPH, University of North Carolina, Chapel Hill;
  • Clinical Value of Motion Synchronization for Lung SBRT: Jonathan W. Lischalk, M.D., Medstar Georgetown University Hospital, Washington, D.C.; and
  • First Site Experience on Real-time Motion Synchronization on the Radixact System: X. Allen Li, Ph.D., DABMP, FAAPM, Medical College of Wisconsin.

Accuray will also feature ongoing interactive discussions with industry experts in its AERO Academy. 

For more information: www.accuray.com

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.